Join CSHP and the Canadian Cardiovascular Pharmacists Network on February 1 for this one-day virtual event delivering an in-depth look at ASCVD. Hear from experts covering diagnosis, assessment, pharmacy’s role, guideline updates, patient perspectives, and more.
Atherosclerotic cardiovascular disease (ASCVD), a chronic condition marked by plaque buildup in the arteries, is a major contributor to cardiovascular health issues and mortality in Canada. It plays a key role in making heart-related diseases the second leading cause of death among Canadians. Healthcare providers must be equipped with the vital tools to support patient care and outcomes.